title: Changing epidemiology of hepatitis A infection in Izmir, Turkey.
abstract: The seroprevalence study was conducted in order to determine the current seroepidemiology hepatitis A in Izmir, Turkey and to evaluate the epidemiological shift in HAV serostatus. Blood samples collected from 595 subjects aged 1-60 years were analyzed for anti-HAV IgG antibodies. The current study results were compared with those of a previous study conducted in 1998 involving the same location. There was a marked decrease in the prevalence of anti-HAV between 1998 and 2008. While anti-HAV seroprevalence rates in the current study were 4.6% in children aged 1-4 years, 23% in children aged 10-14 years, and 85% in young adults aged 20-29 years, the prevalence rates were 36% in the 1-4 years age group, 65% in the 10-14 years age group, and 95% in young adults in the previous study, indicating a shift in HAV seroprevalence from the younger to the higher age groups. As HAV infection in childhood is decreasing, the pool of susceptible adolescents and young adults is increasing in Izmir, Turkey. The majority of adolescent population is susceptible to HAV infection. The potential risk of HAV epidemics still exists. The situation of Turkey, suggested to need for mass immunization. Also, introduction of hepatitis A vaccination into the national immunization schedule of Turkey should be considered.
authors.affiliation: Ege University, Medical Faculty, Department of Pediatrics, 35100 Izmir, Turkey. zafer.kurugol@ege.edu.tr
authors.forename: Zafer
authors.initials: Z
authors.lastname: Kurugol
authors.forename: Asli
authors.initials: A
authors.lastname: Aslan
authors.forename: Ebru
authors.initials: E
authors.lastname: Turkoglu
authors.forename: Guldane
authors.initials: G
authors.lastname: Koturoglu
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D006506:Hepatitis A / Q000097:blood* / Q000453:epidemiology*; D035922:Hepatitis A Antibodies / Q000097:blood*; D035921:Hepatitis A Antigens / Q000276:immunology; D030041:Hepatitis A virus / Q000276:immunology / Q000302:isolation & purification; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D016036:Seroepidemiologic Studies; D011795:Surveys and Questionnaires; D014421:Turkey / Q000453:epidemiology
chemical_list: D035922:Hepatitis A Antibodies; D035921:Hepatitis A Antigens